Advertisement

Association of Vitamin B Status with Risk of Dementia in Cohort Studies: A Systematic Review and Meta-Analysis

      Abstract

      Objective

      To examine the association between B vitamins status and the risk of dementia in older adults through a systematic review and meta-analysis of cohort studies.

      Design

      Systematic review and meta-analysis.

      Setting and participants

      Older adults aged ≥60 years from community, nursing home, institution, or hospital.

      Methods

      PubMed, Cochrane Library, EMBASE, Web of Science, CINAHL, ClinicalTrials, WHO-ICTRP, NHS Trusts, and ACTR were searched from the date of their inception up to November 28, 2021. We included cohort studies that assessed the association between serum B vitamins or B vitamins intake and the risk of dementia among older adults aged ≥60 years. The quality of all studies was assessed by the modified Newcastle-Ottawa Scale (NOS). The hazard ratios (HRs) and 95% CIs were calculated by the random effects model. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach was used to rate the certainty of evidence.

      Results

      Eleven cohort studies with sample sizes ranging from 233 to 3634 were included in the meta-analysis. Levels of serum folate showed statistically significant association with the risk of dementia (≥10 nmol/L: HR 1.57, 95% CI 1.01-2.46, low certainty; <10 nmol/L: HR 0.93, 95% CI 0.88-0.99, very low certainty). However, levels of vitamin B6 intake showed no statistically significant effects on risk of dementia; levels of serum vitamin B12 and vitamin B12 intake also showed no statistically significant effects on risk of dementia in older adults.

      Conclusions and Implications

      The results from our meta-analysis suggest that vitamin B6, B12, and folate may not be modifiable risk factors for dementia among older adults. Current evidence on the relationship between vitamin B status and dementia is not sufficient for development of vitamin B recommendations. More high-quality cohort studies are needed to confirm the relationship between the two in the future.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Madhu L.N.
        • Kodali M.
        • Shetty A.K.
        Promise of metformin for preventing age-related cognitive dysfunction.
        Neural Regen Res. 2022; 17: 503-507
        • D'cruz M.M.
        Does alice live here anymore? Autonomy and identity in persons living and dying with dementia.
        Front Psychiatry. 2021; 12: 700567
        • World Health Organization
        Dementia.
        • Sengoku R.
        Aging and Alzheimer's disease pathology.
        Neuropathology. 2020; 40: 22-29
        • World Health Organization
        Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016.
        World Health Organization, 2018
        • Tsoy E.
        • Sideman A.B.
        • Piña Escudero S.D.
        • et al.
        Global perspectives on brief cognitive assessments for dementia diagnosis.
        J Alzheimers Dis. 2021; 82: 1001-1013
        • Emmady P.D.
        • Tadi P.
        • Del Pozo E.
        Dementia (nursing).
        in: StatPearls. StatPearls Publishing, 2021
        • Williams J.W.
        • Plassman B.L.
        • Burke J.
        • Benjamin S.
        Preventing Alzheimer's disease and cognitive decline.
        Evid Rep Technol Assess (Full Rep). 2010; 193: 1-727
        • Xu W.
        • Tan L.
        • Wang H.F.
        • et al.
        Meta-analysis of modifiable risk factors for Alzheimer's disease.
        J Neurol Neurosurg Psychiatry. 2015; 86: 1299-1306
        • Wang Y.H.
        • Yan Q.H.
        • Xu J.Y.
        • et al.
        High prevalence and factors contributing to hyperhomocysteinemia, folate deficiency, and vitamin B12 deficiency among healthy adults in Shanghai, China.
        Biomed Environ Sci. 2019; 32: 63-67
        • Zhang X.
        • Bao G.
        • Liu D.
        • et al.
        The association between folate and Alzheimer's disease: a systematic review and meta-analysis.
        Front Neurosci. 2021; 15: 661198
        • Zhang C.
        • Luo J.
        • Yuan C.
        • Ding D.
        Vitamin B12, B6, or folate and cognitive function in community-dwelling older adults: a systematic review and meta-analysis.
        J Alzheimers Dis. 2020; 77: 781-794
        • Dangour A.D.
        • Whitehouse P.J.
        • Rafferty K.
        • et al.
        B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.
        J Alzheimers Dis. 2010; 22: 205-224
        • Kalli E.G.
        Association of nutrients with biomarkers of Alzheimer's disease.
        Adv Exp Med Biol. 2017; 987: 257-268
        • Health Quality Ontario
        Vitamin B12 and cognitive function: an evidence-based analysis.
        Ont Health Technol Assess Ser. 2013; 13: 1-45
        • Doets E.L.
        • van Wijngaarden J.P.
        • Szczecińska A.
        • et al.
        Vitamin B12 intake and status and cognitive function in elderly people.
        Epidemiol Rev. 2013; 35: 2-21
        • Cao L.
        • Tan L.
        • Wang H.F.
        • et al.
        Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies.
        Mol Neurobiol. 2016; 53: 6144-6154
        • McCleery J.
        • Abraham R.P.
        • Denton D.A.
        • et al.
        Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.
        Cochrane Database Syst Rev. 2018; 11: CD011905
        • Huque M.F.
        Experiences with meta-analysis in NDA submissions.
        Proc Biopharm Sec Am Stat Assoc. 1988; 2: 28-33
        • Egger M.
        • Smith G.D.
        • Phillips A.N.
        Meta-analysis: principles and procedures.
        BMJ. 1997; 315: 1533-1537
        • Stroup D.F.
        • Berlin J.A.
        • Morton S.C.
        • et al.
        Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
        JAMA. 2000; 283: 2008-2012
        • Page M.J.
        • McKenzie J.E.
        • Bossuyt P.M.
        • et al.
        The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
        BMJ. 2021; 372: n71
        • Wells G.
        The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis.
        • Stang A.
        Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.
        Eur J Epidemiol. 2010; 25: 603-605
        • Higgins J.P.
        • Thompson S.G.
        • Deeks J.J.
        • Altman D.G.
        Measuring inconsistency in meta-analysis.
        BMJ. 2003; 327: 557-560
        • Guyatt G.H.
        • Oxman A.D.
        • Vist G.E.
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • Iorio A.
        • Spencer F.A.
        • Falavigna M.
        • et al.
        Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients.
        BMJ. 2015; 350: h870
        • Wang H.X.
        • Wahlin A.
        • Basun H.
        • et al.
        Vitamin B (12) and folate in relation to the development of Alzheimer's disease.
        Neurology. 2001; 56: 1188-1194
        • Maxwell C.J.
        • Hogan D.B.
        • Ebly E.M.
        Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons.
        Dement Geriatr Cogn Disord. 2002; 13: 225-234
        • Corrada M.M.
        • Kawas C.H.
        • Hallfrisch J.
        • et al.
        Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging.
        Alzheimers Dement. 2005; 1: 11-18
        • Quadri P.
        • Fragiacomo C.
        • Pezzati R.
        • et al.
        Homocysteine and B vitamins in mild cognitive impairment and dementia.
        Clin Chem Lab Med. 2005; 43: 1096-1100
        • Ravaglia G.
        • Forti P.
        • Maioli F.
        • et al.
        Homocysteine and folate as risk factors for dementia and Alzheimer disease.
        Am J Clin Nutr. 2005; 82: 636-643
        • Morris M.C.
        • Evans D.A.
        • Schneider J.A.
        • et al.
        Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease.
        J Alzheimers Dis. 2006; 9: 435-443
        • Luchsinger J.A.
        • Tang M.X.
        • Miller J.
        • et al.
        Relation of higher folate intake to lower risk of Alzheimer disease in the elderly.
        Arch Neurol. 2007; 64: 86-92
        • Middleton L.E.
        • Kirkland S.A.
        • Maxwell C.J.
        • et al.
        Exercise: a potential contributing factor to the relationship between folate and dementia.
        J Am Geriatr Soc. 2007; 55: 1095-1098
        • Fischer P.
        • Zehetmayer S.
        • Jungwirth S.
        • et al.
        Risk factors for Alzheimer dementia in a community-based birth cohort at the age of 75 years.
        Dement Geriatr Cogn Disord. 2008; 25: 501-507
        • Nelson C.
        • Wengreen H.J.
        • Munger R.G.
        • Corcoran C.D.
        Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study.
        J Nutr Health Aging. 2009; 13: 899-905
        • Lefèvre-Arbogast S.
        • Féart C.
        • Dartigues J.F.
        • et al.
        Dietary B vitamins and a 10-year risk of dementia in older persons.
        Nutrients. 2016; 8: 761
        • Hughes C.F.
        • Ward M.
        • Tracey F.
        • et al.
        B-vitamin intake and biomarker status in relation to cognitive decline in healthy older adults in a 4-year follow-up study.
        Nutrients. 2017; 9: 53
        • Malouf R.
        • Grimley Evans J.
        The effect of vitamin B6 on cognition.
        Cochrane Database Syst Rev. 2003; : CD004393
        • Quadri P.
        • Fragiacomo C.
        • Pezzati R.
        • et al.
        Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia.
        Am J Clin Nutr. 2004; 80: 114-122
        • Carney E.
        • Canada T.
        Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons.
        Nutr Clin Pract. 2006; 21: 188-189
        • Seshadri S.
        • Beiser A.
        • Selhub J.
        • et al.
        Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
        N Engl J Med. 2002; 346: 476-483
        • Smith A.D.
        • Refsum H.
        Homocysteine, B vitamins, and cognitive impairment.
        Annu Rev Nutr. 2016; 36: 211-239